13 research outputs found
Average number of annual health care utilization among dually diagnosed patients, by physician mix category.
<p>Average number of annual health care utilization among dually diagnosed patients, by physician mix category.</p
Patient flow for selecting dually diagnosed patients.
<p>Patient flow for selecting dually diagnosed patients.</p
Average number of annual visits to physician specialties among dually diagnosed patients, by physician mix category.
<p>Average number of annual visits to physician specialties among dually diagnosed patients, by physician mix category.</p
Average age and number of comorbidities by physician mix categories by year.
<p>Average age and number of comorbidities by physician mix categories by year.</p
Descriptive distribution of patients who were dually diagnosed with compensated cirrhosis and diabetes by physician mix category, MarketScan 2000–2013.
<p>Descriptive distribution of patients who were dually diagnosed with compensated cirrhosis and diabetes by physician mix category, MarketScan 2000–2013.</p
Distribution of total physician encounters by specialties, 2000–2013.
<p>Distribution of total physician encounters by specialties, 2000–2013.</p
Distribution of physician mix categories among dually diagnosed patients.
<p>Distribution of physician mix categories among dually diagnosed patients.</p
Inclusivity in global research checklist.
Despite the policy recommendation and effectiveness of administering the hepatitis B birth-dose vaccine (HepB-BD) to newborns to prevent mother-to-child hepatitis B transmission, timely uptake remains an issue. Countries adopting the HepB-BD to their national immunization schedule report programmatic challenges to administering the vaccine within the recommended 24-hour window after delivery. Further, while the World Health Organization recommends streamlining three birth-dose vaccines (HepB-BD, BCG, and OPV0), scarce Sub-Saharan(SSA)-based literature reports on a streamlined and timely approach to birth-dose vaccines. As more SSA countries adopt the new birth-dose vaccine to their immunization schedules, a systematically developed implementation strategy—Vaccination of Newborns–Innovative Strategies to Hasten Birth-Dose vaccines’ delivery (VANISH-BD)—will facilitate the adoption and implementation of timely birth-dose vaccine uptake. In this paper, we describe the development of the implementation strategy using intervention mapping, an evidence-based and theory-driven approach. We report on the development of our intervention, beginning with the needs assessment based in Kinshasa Province, Democratic Republic of the Congo (DRC), informing step 1 of intervention mapping. The intervention is contextually relevant, locally produced, sustainable, and designed to improve timely birth-dose vaccine uptake in the DRC. We intend to inform future implementers about improving timely and streamlined birth-dose vaccine uptake and for VANISH-BD to be adapted for similar contexts.</div
Matrices of change.
Despite the policy recommendation and effectiveness of administering the hepatitis B birth-dose vaccine (HepB-BD) to newborns to prevent mother-to-child hepatitis B transmission, timely uptake remains an issue. Countries adopting the HepB-BD to their national immunization schedule report programmatic challenges to administering the vaccine within the recommended 24-hour window after delivery. Further, while the World Health Organization recommends streamlining three birth-dose vaccines (HepB-BD, BCG, and OPV0), scarce Sub-Saharan(SSA)-based literature reports on a streamlined and timely approach to birth-dose vaccines. As more SSA countries adopt the new birth-dose vaccine to their immunization schedules, a systematically developed implementation strategy—Vaccination of Newborns–Innovative Strategies to Hasten Birth-Dose vaccines’ delivery (VANISH-BD)—will facilitate the adoption and implementation of timely birth-dose vaccine uptake. In this paper, we describe the development of the implementation strategy using intervention mapping, an evidence-based and theory-driven approach. We report on the development of our intervention, beginning with the needs assessment based in Kinshasa Province, Democratic Republic of the Congo (DRC), informing step 1 of intervention mapping. The intervention is contextually relevant, locally produced, sustainable, and designed to improve timely birth-dose vaccine uptake in the DRC. We intend to inform future implementers about improving timely and streamlined birth-dose vaccine uptake and for VANISH-BD to be adapted for similar contexts.</div
Determinants, theoretical-based methods, and practical application for each study actor.
Determinants, theoretical-based methods, and practical application for each study actor.</p